+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
INDRAMEDCO

Indraprastha Medical Corporation Share Price

 

 

Indraprastha Medical Corporation live price: ₹380.15. It opened at ₹379 vs previous close ₹381; intraday high/low: ₹384/₹377. The 50 & 200 DMA stand at ₹388.09/₹415.24.

Indraprastha Medical Corporation Performance

  • Today's Low
  • ₹377
  • Today's High
  • ₹384
  • 52 Week Low
  • ₹342
  • 52 Week High
  • ₹641
  • Open Price₹379
  • Previous Close₹381
  • Volume59,605
  • 50 DMA₹388.09
  • 100 DMA₹399.24
  • 200 DMA₹415.24

Indraprastha Medical Corporation Chart

Investment Returns

  • Over 1 Month -1.13%
  • Over 3 Month -13.4%
  • Over 6 Month -7.88%
  • Over 1 Year -22.03%

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Invest Now

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 3,485
  • P/B Ratio
  • 4.7
  • Average True Range
  • 11.73
  • EPS
  • 20.03
  • Dividend Yield
  • 1.2
  • MACD Signal
  • -1.37
  • RSI
  • 47.53
  • MFI
  • 63.6

Latest Stock News Updates

Q4FY26 & FY26 Result Announced for Indraprastha Medical Corporation Ltd.

Healthcare Facilities company Indraprastha Medical Corporation announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 364.81 crore, representing a decrease of 1.83% QoQ from Rs 371.61 crore in Q3FY26 and an increase of 9.31% YoY from Rs 333.75 crore in Q4FY25. For FY26, revenue reached Rs 1,482.51 crore compared to Rs 1,356.36 crore in FY25, marking a growth of 9.30% YoY. Total Income: For Q4FY26, total income was Rs 372.14 crore, a marginal decrease of 1.75% QoQ from Rs 378.76 crore and an increase of 9.42% YoY from Rs 340.10 crore in Q4FY25. The annual total income for FY26 stood at Rs 1,511.26 crore, reflecting a 9.59% YoY growth from Rs 1,379.01 crore in FY25. Profit After Tax (PAT): For Q4FY26, the company reported a PAT of Rs 41.70 crore, showing an increase of 1.71% QoQ from Rs 41.00 crore in Q3FY26 and an increase of 1.68% YoY from Rs 41.01 crore in Q4FY25. The annual PAT for FY26 reached Rs 183.62 crore, representing a growth of 14.06% YoY compared to Rs 160.99 crore in FY25. Earnings Per Share (EPS): The basic and diluted EPS for FY26 was Rs 20.03, up from Rs 17.56 in FY25. Business Highlights: Dividend: The Board of Directors has recommended a final dividend of 40% i.e., Rs 4.00 per equity share (face value of Rs 10 each) for FY26. Segment Performance: The Company operates in a single segment, Healthcare. Accordingly, there are no additional disclosures to be made under Ind AS 108 on Operating Segments. Corporate Structure: As of March 31, 2026, the Company does not have any subsidiary, associate, or joint venture companies. Regulatory Compliance: The Company confirmed that it does not fall under the criteria of "Large Corporate (LC)" as specified by SEBI circulars. Labour Code Impact: The Government of India has consolidated 29 existing labour legislations into four Labour Codes. The Company has accounted for the incremental estimated liability in the statement of audited financial results for the current year. Result PDF

Don't miss out on these 3 must-have breakout stocks for your portfolio

Indraprastha Medical has witnessed a decisive breakout above a key resistance level on the daily timeframe, followed by a healthy retracement that has been absorbed well by the market.

Indraprastha Medical Reaches Fresh All-Time High, Jumps 30% In Two Days Here's Why

The sharp upsurge in Indraprastha shares can be linked to the revisions announced by the Central Government Health Services (CGHS) - its biggest in 15 years.

Indraprastha Medical Corporation Financials

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹380.15
-0.7 (-0.18%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹383.40
  • 50 Day
  • ₹388.10
  • 100 Day
  • ₹399.20
  • 200 Day
  • ₹415.20

Resistance and Support

380.63 Pivot Speed
  • R3 389.67
  • R2 386.58
  • R1 383.72
  • S1 377.77
  • S2 374.68
  • S3 371.82

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Ltd. operates the prestigious Indraprastha Apollo Hospitals in New Delhi, providing world-class healthcare services. It offers a wide range of medical specialties, advanced diagnostics, and state-of-the-art facilities for patients from India and abroad.

Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,482.51 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 17% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited Results & Final Dividend
2026-02-03 Quarterly Results
2025-11-01 Quarterly Results
2025-08-06 Quarterly Results
2025-05-16 Audited Results & Final Dividend
Date Purpose Remarks
2025-09-18 FINAL Rs.4.50 per share(45%)Final Dividend
View Indraprastha Medical Corporation Dividend History Arrow

Indraprastha Medical Corporation Shareholding Pattern

51%
0.01%
0%
2.43%
0%
31.83%
14.73%

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹380 As on 13 July, 2026 | 12:36

The Market Cap of Indraprastha Medical Corporation is ₹3484.9 Cr As on 13 July, 2026 | 12:36

The P/E ratio of Indraprastha Medical Corporation is 19 As on 13 July, 2026 | 12:36

The PB ratio of Indraprastha Medical Corporation is 4.7 As on 13 July, 2026 | 12:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23